Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P10415 (
Bcl-2
)
33,771
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
FKBP14
belongs to the family of FK506-binding proteins (FKBPs). Altered expression of FKBPs has been reported in several malignancies. This study aimed to reveal the expression profile of
FKBP14
in ovarian cancer and evaluate whether
FKBP14
is a molecular target for cancer therapy. We found that the
FKBP14
mRNA level was significantly higher in ovarian cancer tissues than in normal tissues.
FKBP14
expression was then knocked down in two ovarian cancer cell lines, SKOV3 and HO8910 cells, by a lentiviral short hairpin RNA (shRNA) delivery system. Reduced expression of
FKBP14
markedly impaired the proliferative ability of ovarian cancer cells. Additionally, ovarian cancer cells infected with
FKBP14
shRNA lentivirus tended to arrest in the G0/G1 phase and undergo apoptosis. Moreover, knockdown of
FKBP14
induced cell apoptosis via increasing the ratio of Bax to
Bcl-2
. These results indicated that
FKBP14
might be a diagnostic marker for ovarian cancer and could be a potential molecular target for the therapy of ovarian cancer.
...
PMID:RNAi-Mediated Downregulation of FKBP14 Suppresses the Growth of Human Ovarian Cancer Cells. 2713 12
FKBP14
belongs to the family of FK506-binding proteins (FKBPs). Altered expression of FKBPs has been reported in several malignancies. This study aimed to reveal the expression profile of
FKBP14
in ovarian cancer and evaluate whether
FKBP14
is a molecular target for cancer therapy. We found that the
FKBP14
mRNA level was significantly higher in ovarian cancer tissues than in normal tissues.
FKBP14
expression was then knocked down in two ovarian cancer cell lines, SKOV3 and HO8910 cells, by a lentiviral short hairpin RNA (shRNA) delivery system. Reduced expression of
FKBP14
markedly impaired the proliferative ability of ovarian cancer cells. Additionally, ovarian cancer cells infected with
FKBP14
shRNA lentivirus tended to arrest in the G0/G1 phase and undergo apoptosis. Moreover, knockdown of
FKBP14
induced cell apoptosis via increasing the ratio of Bax to
Bcl-2
. These results indicated that
FKBP14
might be a diagnostic marker for ovarian cancer and could be a potential molecular target for the therapy of ovarian cancer.
...
PMID:RNAi-Mediated Downregulation of FKBP14 Suppresses the Growth of Human Ovarian Cancer Cells. 2793 Dec 82